Login to Your Account



Financings Roundup

IPOpalooza Continues with Portola's $122M Offering

By Catherine Shaffer
Staff Writer

Wednesday, May 22, 2013
financings_resized.jpg

Portola Pharmaceuticals Inc. has become the latest biotech to go public in a rush driven by surging financial markets. The South San Francisco-based company has become the 12th biotech in the 2013 IPO class, and another dozen are filed and pending, signaling a definitive end to the long wait for markets to regain avid interest in new biotech opportunities following the market crash of 2008.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription